Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising results. However, the cost of this innovative drug and its supply have become key topics for patients and healthcare providers. While tirzepatide has been approved by regulatory agencies, its expensive nature presents a significant obstacle to many. Discuss